体检说血糖偏高，还没到糖尿病要紧吗

US Preventive Services Task Force (2021). Screening for Prediabetes and Type 2 Diabetes. <https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes>：「at a lower BMI (≥23) if the patient is Asian American」；国家卫生健康委办公厅 (2024). 居民体重管理核心知识（2024 年版）释义：「根据《成年人体重判定》（WS/T 428-2013）行业标准……24.0≤BMI＜28.0 为超重，BMI≥28.0 为肥胖」. <https://www.gov.cn/zhengce/zhengceku/202407/P020240703481519509521.pdf>；Wang L 等 (2021). Prevalence and Treatment of Diabetes in China, 2013-2018. JAMA：「In 2018, among adults with diabetes, 36.7% (95% CI, 34.7%-38.6%) reported being aware of their condition」「These rates did not change significantly from 2013.」<https://doi.org/10.1001/jama.2021.22208>

Pan XR, Li GW, Hu YH, 等 (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 20(4), 537-544. <https://doi.org/10.2337/diacare.20.4.537>；Li G, Zhang P, Wang J, 等 (2014). Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes & Endocrinology, 2(6), 474-480. <https://doi.org/10.1016/S2213-8587(14)70057-9>；Gong Q, Zhang P, Wang J, 等 (2019). Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes & Endocrinology, 7(6), 452-461. <https://doi.org/10.1016/S2213-8587(19)30093-2>；Knowler WC, Barrett-Connor E, Fowler SE, 等 (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM, 346(6), 393-403. <https://doi.org/10.1056/NEJMoa012512>；Diabetes Prevention Program Research Group (2015). Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes & Endocrinology, 3(11), 866-875. <https://doi.org/10.1016/S2213-8587(15)00291-0>；Lee CG, Heckman-Stoddard B, Dabelea D, 等 (2021). Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care, 44(12), 2775-2782. <https://doi.org/10.2337/dc21-1046>（争议方）；Tuomilehto J, Lindström J, Eriksson JG, 等 (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 344(18), 1343-1350. <https://doi.org/10.1056/NEJM200105033441801>；Lindström J, Ilanne-Parikka P, Peltonen M, 等 (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet, 368(9548), 1673-1679. <https://doi.org/10.1016/S0140-6736(06)69701-8>；Uusitupa M, Peltonen M, Lindström J, 等 (2009). Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—secondary analysis of the randomized trial. PLoS ONE, 4(5), e5656. <https://doi.org/10.1371/journal.pone.0005656>（争议方）；健康中国行动推进委员会 (2019). 健康中国行动（2019—2030年），（十四）糖尿病防治行动（湖南省卫生健康委员会转载）. <https://wjw.hunan.gov.cn/wjw/ztzl/knowledge/tzggzcfg/202003/t20200303_11359594.html>